EGPI Firecreek Inc (EFIR)

[KULiquidGold]

Dennis Alexander CEO, LinkedIn-connection to Boehringer Ingelheim Pharmaceuticals!

Interesting note from the company in the latest news release on the bogus PR that came out... "While the Company is currently exploring various business ventures"....., http://www.otcmarkets.com/stock/EFIR/news. ...So what is going on behind the scenes!

Do your own DD, draw your own conclusions before investing.

I found an intriguing LinkedIn connection between EGPI Firecreek, Inc. (EFIR) and Boehringer Ingelheim. Boehringer Ingelheim looks like a $14.5 billion dollar company and is ranked 13th in the Top 20 Pharmaceutical companies. http://www.contractpharma.com/heaps/view/542.

On LinkedIn, Joseph Martino (Clinical Scientist / Oncology Department at Boheringer Ingleheim) endorsed David Alexander for "Mergers & Acquisitions". Joseph Martino also endorsed Dennis for Venture Capital, Corporate Development, Private Equity and Start-ups.

On LinkedIn, Dennis Alexander (EGPI Firecreek, Inc. CEO) endorsed Joseph Martino (Clinical Scientist / Oncology Department at Boheringer Ingleheim)) for his "Clinical Research", "Clinical Development" and "CTMS (Clinical Trials Management System)".

If this is old news here, let me know!

These two guys appear to be in opposite ends of the country. I asked myself what is the connection between the EFIR CEO and a Clinical Scientist at the Oncology Department at Boheringer Ingleheim. Why does this Scientist involved in clinical trials, clinical development, clinical research and drug development endorse the EFIR CEO for "Mergers & Acquisitions" and other related business-financial acumen! LinkedIn endorsement pics below.

1.2 billion shares of EFIR traded on Thursday 4/18/14, could it have been due to the bogus PR or was it coincidence of something else in the hopper! Compliments of EmptyBones... "There were 141 trades on Thursday, that was wholesale buying bigtime. Very few retail...".

If the bogus news drove the volume on Thursday 4/18/14, why after a period of "little to no volume", is there a major spike in volume for 2 days prior to 4/18/14. First, on Friday 2/28/14, volume was around 2.2 billion. Then the following Monday 3/3/14 around 1.4 billion in volume, then relatively quiet again until 4/18/14.



Looked at a few iHub posts back around the 2 day volume spike... "200 MILLION HIT AT .0002, WOW!", "90 million blocks" and "RUMORED MJ PLAY REVERSE MERGER"

Dennis Alexander also appears to have been endorsed by many financial connections on LindedIn.

Boehringer Ingelheim is a "family-owned" company governed by the Board of Managing Directors. http://www.boehringer-ingelheim.com/corporate_profile/management.html

Boehringer Ingelheim, founded in 1885 by Albert Boehringer in Ingelheim, Germany, began with just 28 people employed to manufacture tartaric acid salts. Now, more than 125 years later, we are a global enterprise, employing more than 44,000 people in 50 countries. Our focus is primarily in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. http://us.boehringer-ingelheim.com/our_company.html

Partnering at Boehringer Ingelheim: Looking for new opportunities. Partnering has been a central part of our company’s strategy for many years. We believe in working with others outside our company to build on our prescription medicine, consumer health, contract manufacturing and animal health businesses. In addition other partnering opportunities exist with our external research networking and venture fund teams. http://www.boehringer-ingelheim.com/partnering.html

This article is a bit dated relating to Boehringer sponsorship but interesting "Role of endocannobinoids in neuronal communication in the brain."

The Heinrich Wieland Prize..... research into cannabis and endocannobinoids.... "It is sponsored by Boehringer Ingelheim".....
http://www.marijuana.com/threads/ger-role-of-endocannobinoids-in-neuronal-communication-in-the-brain.158668/
http://www.heinrich-wieland-preis.de/index/wielandboehringer

Last reported share structure of EFIR compliments of ProfitChaser.......http://investorshub.advfn.com/boards/read_msg.aspx?message_id=100791085

last 10Q received on Aug 16, 2013 plainly states
Common stock $0.001 par value, authorized 5,000,000,000 shares as of March 31, 2013,, which is the most recent filing from the company itself, so until the company tells us otherwise I am going with it. Even if it is 20B I see quite a few MJ stocks with more than that trading much higher.

http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=9463879

The following image is Joseph Martino's LinkedIn page with Dennis Alexander Endorsing him.



The following images are Dennis Alexander's LinkedIn page with Joseph Martino Endorsing him.